2021-10-29-港交所-安山金控_2021年报_189页_1mb

financial regulatory comment
carried out a timely identification of self-infection risk or have not noticed any significant adverse events or conditions that may lead to continuous operation. The board will continue to play an active role in medical dividends and seek to reduce the group's long-term risks. Helps the electronic market and maintain the strictest control. Board members carefully check all relevant legal regulations. unfavorable investment return rate.

• State management cost
  changed samples of personnel at 63,514 for research and development with fewer directors of board members at 24,000,000 and more executives at 8,000,000 The total decrease.
  This activity has not been completed as of the end of the entry date. The rate of 35.1% of the yield.
• State taxation and loss of profit
  According to the Hong Kong Financial Accounting Standards No.9, the fair value and accounting policy are used to calculate the realized income.
  Gains or Losses from the sale are recorded in the income statement at the time of sale.
  Dividend income is recognized when declared.
  Other Revenue such as ETF yields or gain/loss on fair value change are recognized in other comprehensive income if the investment is measures at fair value with its changes recognized in other comprehensive income.
• State corporate dividend
  This report ensures timely identification of high risk or have not noticed any significant adverse events or conditions that may lead to continuous operation. The board will continue to play an active role in risk management and ensure good capital structure.
• financial asset valuation
  With the following information, the board measures the fair value of the acquired loans at 102,796,000 Hong Kong dollars and the assumed credit losses are 1,493,000 Hong Kong dollars. The fair value is determined by the discount rate used in the calculation, ranging between 18.16% and 88.16%.
• Optional convertible bonds
  This report contains key information about the company's financial health and strategic direction. It covers various aspects including revenue analysis, profit and loss statements, asset and liability summaries, and future outlook. The company has taken steps to improve its financial standing, though some issues remain pending resolution. These points highlight the core data and trends from the report.
• Capital management
  The board is responsible for maintaining a healthy capital structure, managing liquidity risk, and balancing financial stability with growth opportunities. The group's primary investment activities involve expanding into Asian markets and seeking partnerships that align with its strategic objectives. There has been a significant improvement in cash flow management, enabling the company to allocate funds towards core business areas. Despite the challenges posed by the global economic uncertainty, the company remains focused on achieving sustainable growth and creating value for shareholders.
• General income and matters
  Deliberations will be reported in the financial results, including major transactions and legal considerations. The group has not experienced any significant issues with related party transactions, maintaining its focus on ethical business practices.

Key financial highlights include:

• Revenue and profitability have shown improvement, driven mainly by the partnership business.
• The group successfully raised funds through convertible bond refinancing, enhancing its liquidity position.
• Decentralized operations across various business divisions contribute to its diversified revenue streams, with ongoing efforts to expand market reach and improve operational efficiency.

Future challenges include addressing liquidity risks and ensuring continued growth amidst global economic volatility. The board will continue to monitor these factors closely and implement measures to safeguard financial stability